학술논문
What We Have Gained from Ibogaine: α3β4 Nicotinic Acetylcholine Receptor Inhibitors as Treatments for Substance Use Disorders.
Document Type
Article
Source
Journal of Medicinal Chemistry; 1/12/2023, Vol. 66 Issue 1, p107-121, 15p
Subject
Language
ISSN
00222623